0001209191-21-034705.txt : 20210520 0001209191-21-034705.hdr.sgml : 20210520 20210520203614 ACCESSION NUMBER: 0001209191-21-034705 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210519 FILED AS OF DATE: 20210520 DATE AS OF CHANGE: 20210520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gruskin Daniel CENTRAL INDEX KEY: 0001863053 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38707 FILM NUMBER: 21946308 MAIL ADDRESS: STREET 1: 65 HAYDEN AVENUE STREET 2: 2ND FLOOR CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LogicBio Therapeutics, Inc. CENTRAL INDEX KEY: 0001664106 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 471514975 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 65 HAYDEN AVE STREET 2: 2ND FLOOR CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617-245-0399 MAIL ADDRESS: STREET 1: 65 HAYDEN AVE STREET 2: 2ND FLOOR CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-05-19 0 0001664106 LogicBio Therapeutics, Inc. LOGC 0001863053 Gruskin Daniel C/O LOGICBIO THERAPEUTICS, INC. 65 HAYDEN AVE, FLOOR 2 LEXINGTON MA 02421 0 1 0 0 Chief Medical Officer Employee Stock Option (Right to buy) 4.33 2021-05-19 4 A 0 60000 0.00 A 2031-05-19 Common Stock 60000 60000 D The options were granted by the Issuer pursuant to its 2018 Equity Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal monthly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. /s/ Jonathan Quick, as Attorney-in-Fact 2021-05-20